Send a message of support to patients battling cancer at Nationwide Children's!
We hope you will join us to honor children and families who have fought cancer in the past, support those who are currently in the midst of their fight, and work towards more solutions for the almost 300,000 children who will be diagnosed with cancer around the world in the next year.
Diagnosis and Treatment
Making the Most of 4%
Pediatric cancer research receives just 4% of the federally-funded annual budget from the National Cancer Institute (NCI). Much of this is do the high cure rate of pediatric cancers when compared to cancers in other populations. While the cure rate for pediatric cancer may be comparatively high, the childhood cancer community still relies on support beyond this 4% to provide the necessary research and clinical trials for patients of the rarest cancer diagnoses.
We’ve come a long way with the 4% of funds allocated by the NCI; but we still have a long way to go to provide the future each child effected by pediatric cancer deserves. Imagine what we could do with your help.
"The field has proven that research cures cancer. So we can’t rest until we cure everyone."-Dr. Timothy Cripe MD, PhD, Chief of the Division of Hematology, Oncology and Blood and Marrow Transplant
Research: from Bench to Bedside
Helping Patients on a Global Scale
At Nationwide Children’s, we’re on the cutting edge of solutions for pediatric cancer patients worldwide. Our Hematology, Oncology and Blood and Marrow Transplant teams are leading collaborations to investigate innovative treatments for cancer.
The NEXT Consortium is a collaborative research model that unites multiple research centers with the goal of expediting the most advanced treatments in the shortest timeframe possible in pediatric cancers.
Nationwide Children’s is a leader in virotherapy research, including participating in the first clinical trial of virotherapy in pediatric cancers.
Nationwide Children’s is one of the first pediatric institutions in the country to build a Good Manufacturing Practice facility designed to research the rarest pediatric cancers. The space ensures the highest level of product safety and purity to support more accurate early phase clinical trials.
MIBG, called meta-iodobenzylguanidine, is a chemical that is usually picked up by neural crest cells. Neural crest cells can give rise to a type of cancer called neuroblastoma. Neuroblastomas are in a class of tumors (called neuro-endocrine tumors) that will take up MIBG and can respond to treatment with MIBG. The high-dose radioactive form of MIBG (called I-131 MIBG ) is used for treatment. I-131 MIBG is a very effective medication when used to treat neuroblastoma that has responded well to traditional treatments. Roughly 80-85% of neuroblastomas will absorb MIBG.
Since we aren’t the only ones doing this, what makes us special?
We treat the whole family– period. We don’t forget that the patient beneath the sheets is still a young child. Children receiving therapy with I-131 MIBG must remain in a special room for 3 to 5 days. As such these kids and their families have very special and very unique needs. Our team of physicians, nurses, psychologists, social workers, child life specialists, music therapists, radiation safety specialists, and administrators are experts at tailoring your child’s and family’s treatment experience to meet your unique needs.
When your child is sick, it can be hard to understand what is happening, to make decisions and to juggle family responsibilities. Our Psychosocial Services Team will treat the whole child by assist them in coping with their new cancer diagnosis, minimizing stress and fears about medical procedures and treatments such as chemotherapy and radiation or surgery, and help siblings understand what is happening to their brother or sister.
Cancer Genetics Clinic
Our multidisciplinary team has developed an approach to provide a personalized screening and treatment that helps identify children who may have a condition or family history that increases their chance of receiving a cancer diagnosis.
Going Gold to Crush Cancer
Longer Term Care
Our survivorship Clinics strive to improve the quality of all aspects of life – medical, emotional, educational, and social of the children as they grow into adulthood. Learn more about our clinics.
Cancer survivorship is a journey that doesn’t end after treatment. The effects of the disease and treatments can be felt for decades. Dr. Randal Olshefski team team makes sure childhood cancer survivors at Nationwide Children’s have specialized care that is tailored to their survivorship needs.
Meet Nathan, a three-year-old both with LiFraumeni Syndrome. Now over one year strong from his diagnosis, learn more about his journey to recovery.